Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Chubb
Medtronic
Fuji
Federal Trade Commission
Citi
Baxter

Generated: May 25, 2018

DrugPatentWatch Database Preview

BLENOXANE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Blenoxane, and when can generic versions of Blenoxane launch?

Blenoxane is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in BLENOXANE is bleomycin sulfate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
Summary for BLENOXANE
Drug patent expirations by year for BLENOXANE
Medical Subject Heading (MeSH) Categories for BLENOXANE
Synonyms for BLENOXANE
(3-(2'-(1-(6-amino-2-(3-amino-1-((2,3-diamino-3-oxopropyl)amino)-3-oxopropyl)-5-methylpyrimidin-4-yl)-3-((((2R,3S,4S,5S,6S)-3-(((2R,3S,4S,5R,6R)-4-(carbamoyloxy)-3,5-dihydroxy-6-(hyd
11056-06-7
11056-06-7 (Parent)
1400-95-9
3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxo-propyl)amino]-3-oxo-propyl]-5-methyl-pyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)tetrah
37208-04-1
37293-16-6
37353-43-8
9041-93-4
9041-93-4 (sulfate (salt))
AC-5259
AC1L2I4G
AC1NSEJD
AK-72792
AKOS015896273
AKOS015920266
AKOS022190415
AKOS025402121
AM012241
AN-11149
BC683933
Blenoxane (TN)
Bleo
Bleocin
Bleogin
Bleomicin
Bleomicina
Bleomicina [INN-Spanish]
bleomycin
Bleomycin (sulfate)
Bleomycin [INN:BAN]
Bleomycin [INN]
Bleomycin A(2)
bleomycin a2
Bleomycin A2 & Bleomycin B2
Bleomycin antibiotic complex
Bleomycin B(2)
Bleomycin sulfate
Bleomycin sulfate (salt)
Bleomycin sulfate [Bleomycins]
Bleomycin sulfate [USAN:JAN]
Bleomycin sulfate salt
Bleomycin sulphate
Bleomycin, sulfate
Bleomycin, sulfate (salt)
Bleomycine
Bleomycine [INN-French]
Bleomycins
Bleomycins (complex consisting of bleomycin A2 and B2)
Bleomycinum
Bleomycinum [INN-Latin]
Blexane
BLM
BR-72792
C55H85N17O21S3
C55H86N17O21S3.O4S
CA007530
CCRIS 2470
CCRIS 2754
CS-3071
D06UVD
DB00290
DRG-0045 (mixed bleomycins)
EINECS 232-925-2
HSDB 3208
HY-17565
I06-2155
KB-286964
LMPK14000006
LP120333
LS-44912
LS-524
MolPort-008-155-965
N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide
NDC 0015-3010
NSC 125066
Pingyangmyvin A2
Pleomycin
PubChem18938
roxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)(1H-imidazol-5-yl)methyl)-7-hydroxy-11-(1-hydroxyethyl)-6,8-dimethyl-1,4,9,12-tetraoxo-2,5,10,13-te
s1214
SCHEMBL1599
SCHEMBL1648595
SR-01000941586
SR-01000941586-2
traazapentadecan-15-yl)-[2,4'-bithiazole]-4-carboxamido)propyl)dimethylsulfonium hydrogen sulfate
Zhengguangmycin A2

US Patents and Regulatory Information for BLENOXANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb BLENOXANE bleomycin sulfate INJECTABLE;INJECTION 050443-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb BLENOXANE bleomycin sulfate INJECTABLE;INJECTION 050443-002 Sep 7, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Chubb
US Army
Farmers Insurance
Queensland Health
Fuji
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.